Close Menu

NEW YORK (GenomeWeb) – Clinical Genomics Technologies announced today that it has completed a $26 million financing round.

The company said it will use the proceeds from the financing to commercialize Colvera, its liquid biopsy test for earlier detection of recurrent colorectal cancer, and to advance Colvera for use in CRC screening.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In PLOS this week: preconception carrier screening program results, comparative genomics-based analysis of Elizabethkingia meningoseptica, and more.

Canadian regulators are beginning to share information from new drug studies, Undark reports.

In a column at the Dallas Morning News, the Stanley Medical Research Institute's E. Fuller Torrey says the Human Genome Project hasn't delivered on promised results.

Researchers explore a possible genetic cause for some cases of sudden infant death syndrome, KOMO News reports.